5th Circuit Affirms Dismissal Of Claims Against 5 Brand, Generic Drug Makers
NEW ORLEANS — The Fifth Circuit U.S. Court of Appeals on Feb. 5 affirmed dismissal of a pro se drug liability case against five brand-name and generic pharmaceuticals companies, saying the...To view the full article, register now.
Already a subscriber? Click here to view full article